UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could ...
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic ...
We recently published 10 Stocks Sparking Massive Fortunes. UiPath Inc. (NYSE:PATH) is one of the best performers on Friday. UiPath soared 34.7 percent week-on-week to hit a 19-month high, as investors ...
Zacks Investment Research on MSN
UiPath (PATH) stock sinks as market gains: Here's why
UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day. This change lagged the S&P 500's daily gain of 0.26%. Elsewhere, the Dow gained 0.6%, while the ...
UiPath is showing accelerating revenue growth, improved margins, and raised guidance, signaling strong adoption of its agentic AI products. The company's ARR base at $1.72 billion already exceeds Wall ...
UiPath Chief Marketing Officer Michael Atalla argues that enterprises aren’t moving toward agent-only automation, but toward ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
UiPath, Inc. (NYSE:PATH) reported its fourth-quarter financial results after the bell Wednesday. Here's a look at the highlights. The company reported quarterly earnings of 22 cents per share which ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果